ResearcherTaipei Medical UniversityNo recent work listed

Hsu‐Shan Huang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6193-5182; OpenAlex author ID A5100599868. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2019: 1 paper

Papers 1

Design and Evaluation of PEGylated Liposomal Formulation of a Novel Multikinase Inhibitor for Enhanced Chemosensitivity and Inhibition of Metastatic Pancreatic… Last author DOI 10.1021/acs.bioconjchem.9b00632 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Vijay Sagar Madamsetty · 1 shared paper, 2019 · strength 0.09
- Paper Design and Evaluation of PEGylated Liposomal Formulation of a Novel Multikinase Inhibitor for Enhanced Chemosensitivity… DOI 10.1021/acs.bioconjchem.9b00632 ↗
Krishnendu Pal · 1 shared paper, 2019 · strength 0.09
- Paper Design and Evaluation of PEGylated Liposomal Formulation of a Novel Multikinase Inhibitor for Enhanced Chemosensitivity… DOI 10.1021/acs.bioconjchem.9b00632 ↗
Kabir Mody · 1 shared paper, 2019 · strength 0.09
- Paper Design and Evaluation of PEGylated Liposomal Formulation of a Novel Multikinase Inhibitor for Enhanced Chemosensitivity… DOI 10.1021/acs.bioconjchem.9b00632 ↗
Debabrata Mukhopadhyay · 1 shared paper, 2019 · strength 0.09
- Paper Design and Evaluation of PEGylated Liposomal Formulation of a Novel Multikinase Inhibitor for Enhanced Chemosensitivity… DOI 10.1021/acs.bioconjchem.9b00632 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.